Simtuzumab
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Gilead Sciences
Overview
Simtuzumab is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Simtuzumab clinical trials
Explore related
Medical disclaimer. This page summarizes research about Simtuzumab for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.